Eritropiu 80mg effervescnt Tablets

국가: 몰타

언어: 영어

출처: Medicines Authority

지금 구매하세요

Download 환자 정보 전단 (PIL)
28-05-2024
Download 제품 특성 요약 (SPC)
28-05-2024

유효 성분:

FERROUS GLUCONATE

제공처:

Alta Care Laboratoires Piazza di Spagna 6, 00187 Roma, Italy

ATC 코드:

B03AA03

INN (International Name):

FERROUS GLUCONATE 695 mg

약제 형태:

EFFERVESCENT TABLET

구성:

FERROUS GLUCONATE 695 mg

처방전 유형:

POM

치료 영역:

ANTIANEMIC PREPARATIONS

승인 상태:

Authorised

승인 날짜:

2007-06-28

환자 정보 전단

                                1 
PACKAGE LEAFLET: INFORMATION FOR THE USER 
 
ERITROPIU 80 MG TABLETS 
Ferrous Gluconate 
 
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE. 
Keep this leaflet. You may need to read it again. If you
have any further questions, ask your doctor. This 
medicine has been prescribed for you. Do not pass it on to
others. It may harm them, even if their symptoms 
are the same as yours. If  any of the side effects gets
serious, or if you notice any side effects not listed in this 
leaflet, please tell your doctor. 
 
1. 
WHAT ERITROPIU IS AND WHAT IT IS USED FOR 
Eritropiu are effervescent tablets used for
anaemia and lack of iron treatment. 
 
2. 
BEFORE YOU TAKE ERITROPIU 
A precise diagnosis of anaemia sideropenic must precede treatment.
The administration of iron may be toxic, 
especially in children, at doses higher than 400mg (more than 5
tablets). 
ATTENTION: each Eritropiu effervescent tablet
contains phenylalanine source.   
ATTENTION: each Eritropiu effervescent tablet contains
180.91mg or 8.01 meq. of sodium. 
 
DO NOT TAKE ERITROPIU  
If you are hypersensitive (allergic) to it’s active substance
or any of the other ingredients  
 
TAKE SPECIAL CARE WITH ERITROPIU AND INFORM YOUR DOCTOR  
if you are pregnant or breastfeeding as you may require a
different iron supplement or dose adjustment 
if you have hereditary problems dealing with iron
(Hemosiderosis, hemochromatosis, all non sideropenic 
anaemic forms, particularly haemolytic anaemia, chronic
pancreatitis, hepatic cirrhosis). 
 
TAKING OTHER MEDICINES 
Please tell your doctor if you are taking or have
recently taken any other medicines, including medicines 
obtained without a prescription. The efficacy of Eritropiu may be
altered if administered simultaneously with 
tetracyclines, anti-acids, quinolones. 
 
Eritropiu is best absorbed on an empty stomach
                                
                                전체 문서 읽기
                                
                            

제품 특성 요약

                                 
Page 1 of 5 
   SUMMARY 
OF 
PRODUCT 
CHARACTERISTICS 
 
1. 
NAME OF THE MEDICINAL PRODUCT 
 
ERITROPIU 80 mg EFFERVESCENT TABLETS 
 
2. 
QUALITATIVE AND QUANTITATIVE COMPOSITION 
 
Each effervescent tablet contains: 
Active Ingredient:  
 
Ferrous Gluconate 695mg (equivalent to 80mg of Fe
++
). 
Excipient(s): 
For a full list of excipients, see section 6.1. 
 
3. PHARMACEUTICAL 
FORM 
 
Effervescent tablets. 
 
4. CLINICAL 
PARTICULARS 
 
4.1 THERAPEUTIC 
INDICATIONS 
 
Anaemia and lack of iron treatment. 
 
4.2  POSOLOGY AND METHOD OF ADMINISTRATION 
The daily need of (males) is generally 13 
µg/kg or 1 mg per day. 
The daily need for females (normal menstruation) is generally of 21 
µg/kg or 1.4 mg per day. 
During the last six months of pregnancy, the need increases: 80 
µg/kg per day or, generally, from 5 to 6 
mg per day. 
Children: 22 
µg/kg. 
In case of iron deficiency, the dose must be between 50 and 250
mg per day, according to the anaemic 
level.  
  
POSOLOGY 
Adults: 1 effervescent tablet a day, diluted in water ½ hour before
meal.  
In case of severe anaemia: the dose may be modified according to the
doctor’s judgement according to 
the haematological examinations that are to be done 2 or 3 times a
week after commencing treatment.   
Children: ½ to 1 tablet according to body weight. 
If anaemia persists after three weeks of treatment, another reason
should be sought. 
 
4.3 CONTRAINDICATIONS 
 
Hypersensitivity to the active ingredient or to any of its excipients.
 
Hemosiderosis, hemochromatosis, all non sideropenic anaemic forms,
particularly haemolytic anaemia, 
chronic pancreatitis, hepatic cirrhosis. 
 
4.4  SPECIAL WARNINGS AND PRECAUTIONS FOR USE 
 
A precise diagnosis of anaemia sideropenic must precede treatment. The
administration of iron may be 
toxic, especially in children, at doses higher than 400mg (more than
5 tablets). 
 
Page 2 of 5 
ATTENTION: each ERITROPIU effervescent tablet contai
                                
                                전체 문서 읽기